BIOAGE LABS
bioagelabs.comLocations
San Francisco, CA, USA · Richmond, CA, USA
industry
Biotechnology · Consumer Products · DeepTech · Hardware
Size
51-200 employees
Stage
Series C+
founded in
2015
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.
Something looks off?Open jobs at BIOAGE LABS
On-site & Remote
Job function
Salary